Depression: all 8,240 studies
Page 79 of 83. Open to participants first (1,641), then studies with results posted, then the rest; newest registration first within each.
- A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive DisorderCompletedNCT00368030Phase 3
- Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00366652Phase 3
- A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar DepressionCompletedNCT00363337Phase 4
- An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive DisorderCompletedNCT00361491Phase 2
- Effect of the 'Mother and Baby' Program on Well-BeingCompletedNCT00361478Phase 3
- Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young AdolescentsCompletedNCT00360451Phase 3
- RU-486 in the Treatment of Bipolar DepressionWithdrawnNCT00359125Phase 2
- An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive DisorderCompletedNCT00358631Phase 2
- Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of ParoxetineCompletedNCT00357045Phase 4
- The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and ResponseTerminatedNCT00356655Not applicable
- Interpersonal Psychotherapy for Depression in People With Heart FailureCompletedNCT00353223Phase 1/2
- Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and AdolescentsCompletedNCT00353028Phase 4
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351910Phase 3
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351169Phase 3
- Medical Utilization in Israel During Second IntifadaStatus unknownNCT00350675
- Profile of Depressive Symptoms in Parkinsons DiseaseCompletedNCT00349310
- Group Intervention for Interpersonal TraumaCompletedNCT00348036Not applicable
- A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive DisorderCompletedNCT00345098Phase 3
- Personality-targeted Interventions for Adolescent Alcohol MisuseCompletedNCT00344474Phase 2/3
- Functional Neuroimaging in DepressionCompletedNCT00343070Phase 2
- Effect of Brain Lesion Severity on Treatment Response in Late-Life DepressionCompletedNCT00339066Not applicable
- Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral TherapyCompletedNCT00338767Phase 2
- A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)CompletedNCT00336713Phase 3
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.Status unknownNCT00335205Phase 4
- Determining Optimal Continuation Treatment Duration for Depressed Children and AdolescentsCompletedNCT00332787Not applicable
- Light Therapy for Elderly DepressionTerminatedNCT00332670Phase 2/3
- Exercise Training Versus Drug Therapy for Treating Depression in Older AdultsCompletedNCT00331305Phase 3
- Effect of Ethanol and Genetic Polymorphisms on Bupropion MetabolismWithdrawnNCT00330434Not applicable
- Pennsylvania Adolescent Intervention Research Study (PAIRStudy)TerminatedNCT00329199Phase 2
- Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00329147Phase 3
- Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar DisorderWithdrawnNCT00327756Phase 2
- Primary Prevention of Major Depression in Later LifeCompletedNCT00326677Not applicable
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive DisordersCompletedNCT00326144Phase 3
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive DisordersCompletedNCT00326105Phase 3
- Phase II Study to Assess RG2417 in the Treatment of Bipolar I DepressionCompletedNCT00322764Phase 2
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive DisorderCompletedNCT00321490Phase 3
- A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)CompletedNCT00321152Phase 4
- Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major DepressionCompletedNCT00320632Phase 4
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderCompletedNCT00320268Phase 3
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With DepressionCompletedNCT00319709Phase 3
- RCT of Psychoeducational Program of DepressionCompletedNCT00319540Phase 2
- Nicotinic Receptor Augmentation of SSRI AntidepressantsCompletedNCT00319319Phase 2
- Biological CVD Risk Factors in Older Depressed PatientsCompletedNCT00318864Not applicable
- Trial of Citalopram for the Prevention of DepressionCompletedNCT00317746Phase 3
- Implementing Telemedicine-Based Collaborative Care for MDD in Contract CBOCsWithdrawnNCT00317018Not applicable
- Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity DisorderCompletedNCT00316290Not applicable
- Sexual Functioning Study With AntidepressantsCompletedNCT00316160Phase 4
- Ropinirole in the Treatment of Bipolar DepressionCompletedNCT00314821Phase 4
- Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By CancerStatus unknownNCT00313573Phase 3
- Creatine as a New Therapeutic Strategy in DepressionTerminatedNCT00313417Phase 4
- BDNF Gene Polymorphism and Antidepressants TreatmentCompletedNCT00308893Phase 4
- A Letter Intervention in Primary Care Patients to Improve Depression and Anxiety DisordersCompletedNCT00307697Phase 1
- Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic StimulationCompletedNCT00305045Not applicable
- Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major DepressionCompletedNCT00300404Phase 3
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderCompletedNCT00300378Phase 3
- The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECTCompletedNCT00299403Phase 2/3
- A Quality of Life Study in Patients With MigrainesTerminatedNCT00298805
- Effect of Home-Based Peer Support on Maternal-Infant Interaction and Postpartum DepressionCompletedNCT00298311Not applicable
- Memory Functioning and Antidepressant TreatmentCompletedNCT00296933Phase 3
- Treatment of Depression Following Multiple Brain TestsCompletedNCT00296777Phase 4
- Are Two Antidepressants a Good Initial Treatment for Depression?CompletedNCT00296712Phase 4
- A Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionCompletedNCT00296699Phase 4
- Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory DepressionTerminatedNCT00296686Phase 4
- Evaluating the Effectiveness of Brief Interpersonal Psychotherapy for Pregnant Women With DepressionCompletedNCT00292903Not applicable
- Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major DepressionStatus unknownNCT00291239Phase 4
- Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive DisorderCompletedNCT00290914Phase 2
- Yoga Breath Program and Client-Centered Exposure for Relief of PTSD in Tsunami VictimsCompletedNCT00290225Phase 3
- EEG Biomarkers for Predicting Response to Antidepressant TherapyCompletedNCT00289523
- A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major DepressionStatus unknownNCT00289484Phase 2
- Hospital Based Group Intervention for Breast Cancer Patients.CompletedNCT00289432Not applicable
- Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of DepressionCompletedNCT00287703Phase 3
- Testosterone and Major DepressionCompletedNCT00286546
- Cellular Aging and Neurobiology of Depression StudyCompletedNCT00285935Not applicable
- Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major DepressionCompletedNCT00285766Phase 3
- Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With ResponseCompletedNCT00285376Phase 3
- Lamotrigine in Treatment Resistant Depression in AdolescentsTerminatedNCT00284791Not applicable
- Zinc, Mental Health, and School Performance in Guatemalan SchoolchildrenCompletedNCT00283660Not applicable
- Identification and Therapy of Postpartum DepressionCompletedNCT00282776Phase 3
- Study of Treatments for Depression Among Displaced Adolescents in Northern Uganda.CompletedNCT00280319Not applicable
- Prevention of Suicide in Primary Care Elderly: Collaborative Trial (PROSPECT)CompletedNCT00279682Phase 4
- Depression and Increased Health Services Utilization Among Elderly Primary Care PatientsCompletedNCT00279526
- Antidepressant Use During PregnancyCompletedNCT00279370
- Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive DisorderCompletedNCT00278941Phase 3
- Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive DisorderCompletedNCT00277823Phase 3
- Lexapro in the Treatment of Patients With Postpartum DepressionCompletedNCT00277108Not applicable
- Aripiprazole Augmentation Therapy in Treatment-resistant DepressionWithdrawnNCT00276978Phase 3
- Bipolar II Depression: Lithium, SSRI, or the CombinationCompletedNCT00276965Phase 3
- Sertraline for the Prevention of Recurrent Postpartum DepressionCompletedNCT00276900Phase 3
- Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled TrialWithdrawnNCT00273624Phase 3
- Treatment Resistant Bipolar DepressionTerminatedNCT00272025Phase 1
- Group Interpersonal Psychotherapy for Depressed Adolescents in School-based ClinicsCompletedNCT00270244Phase 2
- Clinical Pharmacogenomics of Antidepressant ResponseStatus unknownNCT00269334Phase 4
- Quality of Life in African-American or Caucasian Female Breast Cancer SurvivorsCompletedNCT00268502
- Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research GroupCompletedNCT00265291Phase 2
- GW679769 In FibromyalgiaCompletedNCT00264628
- ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health RegistryCompletedNCT00264069
- Modulation of Visually Evoked Potentials by an AntidepressantCompletedNCT00263133Not applicable
- Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive DisorderWithdrawnNCT00262665Phase 2
- Brain Abnormalities in Late-Onset Major DepressionCompletedNCT00260468
- Genetics of Recurrent Early Onset Major DepressionCompletedNCT00260182